Legend Biotech (LEGN) has filed to raise $350 million in an IPO of its ADSs representing ordinary shares, per an amended registration statement. The company is advancing a pipeline of treatments for …
( read original story …)
Legend Biotech (LEGN) has filed to raise $350 million in an IPO of its ADSs representing ordinary shares, per an amended registration statement. The company is advancing a pipeline of treatments for …
( read original story …)